Galectin Therapeutics Reports First Quarter 2015 Financial Results, Provides Business Update Including Phase 2 NASH Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. EROC
4. FRBT
5. SEER
6. IBM
7. ONDS
8. TSLA
9. SEI
10. PBLS

Go back to Galectin Therapeutics Reports First Quarter 2015 Financial Results, Provides Business Update Including Phase 2 NASH Program
GALECTIN (NASDAQ: GALT) Delayed: 4.51 --0 (-0%)
Previous Close $4.51    52 Week High $3.05 
Open $4.51    52 Week Low $0.49 
Day High $4.51    P/E N/A 
Day Low $4.51    EPS $-1.32 
Volume 444